Browse by ORCID

Journal article

FERRI, C., DI BIASE, A., BOCCHETTI, M., ZAPPAVIGNA, S., WAGNER, S., LE VU, P., LUCE, A., COSSU, A.M., VADAKEKOLATHU, J., MILES, A., BOOCOCK, D.J., ROBINSON, A., SCHWERDTFEGER, M., TIRINO, V., PAPACCIO, F., CARAGLIA, M., REGAD, T. and DESIDERIO, V., 2022. MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer. Journal of Experimental and Clinical Cancer Research, 41 (1): 40. ISSN 1756-9966

COOK, K., XUE, W., SYMONDS, P., DANIELS, I., GIJON, M., BOOCOCK, D., COVENEY, C., MILES, A., SHAH, S., ATABANI, S., CHOUDHURY, R., VAGHELA, P., WESTON, D., METHERINGHAM, R., BRENTVILLE, V. and DURRANT, L., 2021. Homocitrullination of lysine residues mediated by myeloid derived suppressor cells in the tumour environment is a target for cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 9 (7): e001910.

GRUET, M., COTTON, D., COVENEY, C., BOOCOCK, D.J., WAGNER, S., KOMOROWSKI, L., REES, R.C., POCKLEY, A.G., GARNER, A.C., WALLIS, J.D., MILES, A.K. and POWE, D.G., 2020. β2-adrenergic signalling promotes cell migration by upregulating expression of the metastasis-associated molecule LYPD3. Biology, 9 (2): 39. ISSN 2079-7737

ALDISS, P., LEWIS, J.E., LUPINI, I., BLOOR, I., RAMYAR, C., BOOCOCK, D.J., MILES, A.K., EBLING, F.J.P., BUDGE, H. and SYMONDS, M.E., 2020. Exercise training in obese rats does not induce browning at thermoneutrality and induces a muscle-like signature in brown adipose tissue. Frontiers in Endocrinology, 11: 97. ISSN 1664-2392

AL-JUBOORI, S.I.K., VADAKEKOLATHU, J., IDRI, S., WAGNER, S., ZAFEIRIS, D., PEARSON, J.R.D., ALMSHAYAKHCHI, R., CARAGLIA, M., DESIDERIO, V., MILES, A.K., BOOCOCK, D.J., BALL, G.R. and REGAD, T., 2019. PYK2 promotes HER2-positive breast cancer invasion. Journal of Experimental & Clinical Cancer Research, 38: 210. ISSN 1756-9966

ALDISS, P., LEWIS, J., BOOCOCK, D., MILES, A., BLOOR, I., EBLING, F., BUDGE, H. and SYMONDS, M., 2019. Interscapular and perivascular brown adipose tissue respond differently to a short-term high-fat diet. Nutrients, 11 (5): 1065. ISSN 2072-6643

ABDEL-FATAH, T.M.A., REES, R.C., POCKLEY, A.G., MOSELEY, P., BALL, G.R., CHAN, S.Y.T., ELLIS, I.O. and MILES, A.K., 2017. The localisation of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. Oncotarget, 8, pp. 112245-112257. ISSN 1949-2553

KOGOU, S., NEATE, S., COVENEY, C., MILES, A., BOOCOCK, D., BURGIO, L., CHEUNG, C.S. and LIANG, H., 2016. The origins of the Selden map of China: scientific analysis of the painting materials and techniques using a holistic approach. Heritage Science, 4 (28). ISSN 2050-7445

BUCZEK, M.E., MILES, A.K., GREEN, W., JOHNSON, C., BOOCOCK, D.J., POCKLEY, A.G., REES, R.C., HULMAN, G., VAN SCHALKWYK, G., PARKINSON, R., HULMAN, J., POWE, D.G. and REGAD, T., 2016. Cytoplasmic PML promotes TGF-β-associated epithelial–mesenchymal transition and invasion in prostate cancer. Oncogene, 35, pp. 3465-3475. ISSN 0950-9232

MATHIEU, M.G., MILES, A.K., AHMAD, M., BUCZEK, M.E., POCKLEY, A.G., REES, R.C. and REGAD, T., 2014. The helicase HAGE prevents interferon-a-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death and Disease, 5 (2). ISSN 2041-4889

MATHIEU, M.G., MILES, A.K., AHMAD, M., BUCZEK, M.E., POCKLEY, A.G., REES, R.C. and REGAD, T., 2014. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death & Disease, 5 (2). ISSN 2041-4889

LAVERSIN, S.A.-S., PHATAK, V.M., POWE, D.G., LI, G., MILES, A.K., HUGHES, D.C., BALL, G.R., ELLIS, I.O., GRITZAPIS, A.D., MISSITZIS, I., MCARDLE, S.E.B. and REES, R.C., 2013. Identification of novel breast cancer-associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells. Genes, Chromosomes and Cancer, 52 (3), pp. 316-329. ISSN 1098-2264

LINLEY, A.J., MATHIEU, M.G., MILES, A.K., REES, R.C., MCARDLE, S.E.B. and REGAD, T., 2012. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tunor cell proliferation in vivo. Journal of Biological Chemistry, 287 (17), pp. 13633-13643.

VAFADAR-ISFAHANI, B., LAVERSIN, S.A., AHMAD, M., BALL, G., COVENEY, C., LEMETRE, C., MILES, A.K., VAN SCHALKWYK, G., REES, R.C. and MATHAROO-BALL, B., 2010. Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model. Proteomics Clinical Applications, 4 (89), pp. 682-696. ISSN 1862-8346

LINLEY, A.J., MILES, A.K., AL-FAWAZ, M., LU, C., MCARDLE, S.E.B., REES, R.C. and MATHIEU, M.G., 2009. Non-X-linked cancer/testis antigens: identification, expression profile and immunogenicity [review]. Current Trends in Immunology.

LI, G., ASSUDANI, D.P., LINE, A., CAO, A., MILES, A., REES, R.C. and MCARDLE, S.E.B., 2008. Identification of metastasis associated antigen 1 (MTA1) by serological screening of prostate cancer cDNA libraries. Open Biochemistry Journal, 2, pp. 100-107.

MILES, A.K., ROGERS, A., PARKINSON, R., REES, R.C. and MCARDLE, S.E., 2008. Overview of prostate biomarkers as potential targets for immunotherapy [review]. Current Cancer Therapy Reviews, 4 (2), pp. 86-95.

ASSUDANI, D.P., LI, G., LINE, A., FUMING, C., MILES, A.K., REES, R.C. and MCARDLE, S.E., 2008. SEREX analysis of prostate cancer cDNA libraries: identification of metastasis associated antigen (MTA1) [in press]. Open Biochemistry Journal.

MATHAROO-BALL, B., MILES, A.K., CREASER, C.S., BALL, G. and REES, R., 2008. Serum biomarker profiling in cancer studies: a question of standardisation? Veterinary and Comparative Oncology, 6 (4), pp. 224-247. ISSN 1476-5829

MILES, A.K., ROGERS, A., LI, G., SETH, R., POWE, D., MCARDLE, S.E., MCCULLOCH, T.A., BISHOP, M.C. and REES, R.C., 2007. Identification of a novel prostate cancer-associated tumor antigen. Prostate, 67 (3), pp. 274-287. ISSN 0270-4137

MILES, A.K., MATHAROO-BALL, B., LI, G., AHMAD, M. and REES, R.C., 2006. The identification of human tumour antigens: current status and future developments. Cancer Immunology Immunotherapy, 55 (8), pp. 996-1003. ISSN 0340-7004

LI, G., ALI, S.A., MCARDLE, S.E., MIAN, S., AHMAD, M., MILES, A. and REES, R.C., 2005. Immunity to tumour antigens. Current Pharmaceutical Design, 11 (27), pp. 3501-3509. ISSN 1381-6128

LI, G., MILES, A., LINE, A. and REES, R.C., 2004. Identification of tumour antigens by serological analysis of cDNA expression cloning. Cancer Immunology Immunotherapy, 53 (3), pp. 139-143. ISSN 0340-7004

Chapter in book

DI BIASE, A., MILES, A.K. and REGAD, T., 2018. Generation of in vitro model of epithelial mesenchymal transition (EMT) via the expression of a cytoplasmic mutant form of promylocytic leukemia protein (PML). In: G. PAPACCIO and V. DESIDERIO, eds., Cancer stem cells. Methods in molecular biology (1692). New York: Humana Press, pp. 129-138. ISBN 9781493974009

VADAKEKOLATHU, J., MILES, A.K., BOOCOCK, D.J. and MCARDLE, S.E.B., 2014. Identification of tumor antigens for clinical evaluation. In: Tumor immunology and immunotherapy. Oxford: Oxford University Press, pp. 127-129. ISBN 9780199676866